Elicio Therapeutics ELTX
NASDAQ ELTX
$1.94 +0.27 (+16.17%)
At close: Oct 22, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Selling, General & Administrative (2020 - 2026)

Updated

Elicio Therapeutics' Selling, General & Administrative was $3.62 million in Q2 2026, up 17.3% from $3.09 million a year earlier but down 5.9% from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Selling, General & Administrative (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Elicio Therapeutics' Selling, General & Administrative was $14.23 million through Jun 30, 2026, up 19.1% year-over-year; for FY2025, it was $12.81 million, up 13.1% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of -6.6% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $11.33 million in FY2024 (-4.8%), $11.9 million in FY2023 (+111.3%), $5.63 million in FY2022 (-69.5%) and $18.49 million in FY2021 (+2.8%).
  • Quarterly Selling, General & Administrative has moved between $1.18 million (Q3 2022) and $4.47 million (Q1 2022) over five years.
  • Compared with a year earlier, Selling, General & Administrative has increased for three straight quarters, with growth averaging 9.6% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2023 (growth of 198.0%); the worst was Q2 2022 (a decline of 72.6%).
  • Per Business Quant data, ELTX's Selling, General & Administrative in the three quarters before Q2 2026 was $3.85 million (Q1 2026), $3.76 million (Q4 2025) and $3.01 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 6.29 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 3.63 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 5.65 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 1.92 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 3.41 Bn
10 Elicio Therapeutics 42.49 Mn -35.13 Mn - 3.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.62 Mn
Mar 31, 2026 3.85 Mn
Dec 31, 2025 3.76 Mn
Sep 30, 2025 3.01 Mn
Jun 30, 2025 3.09 Mn
Mar 31, 2025 2.96 Mn
Dec 31, 2024 2.77 Mn
Sep 30, 2024 3.14 Mn
Jun 30, 2024 2.74 Mn
Mar 31, 2024 2.68 Mn
Dec 31, 2023 3.24 Mn
Sep 30, 2023 3.51 Mn
Jun 30, 2023 2.83 Mn
Mar 31, 2023 2.32 Mn
Dec 31, 2022 1.67 Mn
Sep 30, 2022 1.18 Mn
Jun 30, 2022 1.19 Mn
Mar 31, 2022 4.47 Mn
Dec 31, 2021 4.21 Mn
Sep 30, 2021 3.93 Mn
API Access

Elicio Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ELTX&period=max&api_key=YOUR_API_KEY